| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
In medical imaging, AI is primarily used to assist radiologists in detecting abnormalities more accurately and quickly, leading to better diagnoses and more effective treatment planning, which ultimately improves patient outcomes. |
Topol, E., 2019, Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI in radiology provides an additional layer of review, helping radiologists confirm findings, catch overlooked abnormalities, and reduce diagnostic errors. It functions like a second opinion, enhancing confidence in medical decisions. |
Topol, E., 2019, Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
AI literacy refers to a person’s ability to comprehend how AI works, its applications, limitations, and ethical considerations. In medical contexts, this helps professionals use AI tools effectively and safely. |
AI literacy is essential for informed adoption, ensuring technology supports rather than undermines clinical decision-making. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
Factors influencing AI acceptability among healthcare professionals include trust, perceived usefulness, ease of use, and understanding of AI. The color or aesthetic of the machines is irrelevant and not mentioned as a factor. |
Acceptability depends on practical, cognitive, and ethical considerations, not superficial attributes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Social influence—such as the opinions of colleagues, supervisors, or professional networks—can impact whether healthcare professionals adopt AI tools, by shaping trust, perceived norms, and confidence in the technology. |
Adoption of AI is not purely individual; it is socially mediated, meaning peer and organizational attitudes play a key role. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
One common perceived threat of AI in healthcare is that it might replace human professionals, causing fear of job loss or reduced clinical autonomy. This concern affects willingness to adopt AI tools. |
While AI supports decision-making, it is meant to augment rather than replace healthcare professionals, addressing efficiency and accuracy rather than human roles. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
AI acceptability increases when systems are designed around the needs, workflows, and expertise of healthcare professionals, making them intuitive, trustworthy, and supportive rather than disruptive. |
Human-centred design ensures AI tools augment clinical work, fit naturally into medical practice, and address users’ concerns, thereby promoting adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
Human-centred design ensures AI tools augment clinical work, fit naturally into medical practice, and address users’ concerns, thereby promoting adoption. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Because it is consistent with the main idea that the acceptance of new technologies in the professional industry, especially in health, often depends on whether the technology is consistent with existing ethical principles and values or not. |
The main idea that supports this concept is the "Theoretical Framework of Acceptability" (TFA), which states that acceptance is a diverse element that reflects the extent to which people consider health interventions appropriate. Based on experience or thought perception In the context of AI, ethics is an important part of this perception. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Therefore, it is not possible to give a detailed reason or directly refer to external sources. However, in the context of future AI acceptance studies, a deep consideration of user experience and system integration is an emphasized approach in many studies. Because these factors are important for the successful implementation of AI in practice |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson's disease is primarily caused by the loss of dopamine-producing neurons in a specific area of the brain. The main objective of using human embryonic stem cells in treating this disease is to differentiate these stem cells into functional dopamine neurons and transplant them into the affected area to replace the lost cells. This aims to restore dopamine levels and alleviate the symptoms of the disease. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
STEM-PD product testing for safety and effectiveness is generally conducted in many experimental animals in the pre-clinical stage (pre-clinical stage), including mice (mice, rats) and in the advanced stage or to confirm the results before the trial in humans. Large laboratory animals such as monkeys (monkeys) may be used, which have a nervous system closer to humans than mice. [No specific information was found in the results provided. But according to scientific research principles Testing in monkeys is often an important step before human experiments for complex medical products. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
3 months |
|
The image presents a multiple-choice homework question asking for the duration of a preclinical safety study in rats mentioned in an article. Although the specific article is not provided, the user interface and context strongly indicate this is a conceptual homework problem with a single correct answer expected from the provided options. Based on the format and typical educational context, the correct option is identified as 3 Months. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The question asks for the specific clinical trial phase mentioned for the STEM-PD project. This is a conceptual question requiring knowledge of a specific research project's details. The answer is based on the information provided within the context of the educational material from which the image is taken. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The production of medical products such as STEM-PD requires a strict and controlled process to reduce the risk of contamination, error and product irregularity. Compliance with GMP (Good Manufacturing Practice) is a universal regulation for the pharmaceutical and biological products industry. To ensure that the product is safe and of the required quality |
The main principle of GMP is to control every stage of production. From the selection of raw materials, production process, packaging, storage and transportation to be traceable and ensure that all products have the same quality. This standard is supported by health regulators around the world such as the FDA (USA) and EMA (Europe). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
From The Given Options, The One That Indicates That There Are No Side Effects Or Tumor Formation (There Were No Adverse Effects Or Tumor Formation) Is The One That Best Confirms The Safety Of The Product. Scientifically, Testing The Safety Of Medical Products In Experimental Animals Such As Rats Is Necessary To Show That There Are No Serious Dangers Or Unwanted Side Effects. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
From a safety study in experimental mice on STEM-PD cells, it was found that the cells were safe. By staying within the transplant site for a long time without signals spread to other parts of the body and there are no signs of toxicity or tumor formation. The aim of this research is to replace the lost neurons that produce dopamine. Which is the cause of movement disorders in Parkinson's disease Therefore, the important research results are that transplanted cells can reverse the movement disorders in laboratory rats. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
GIRK2 (G protein-activated inward rectifier potassium channel 2) and ALDH1A1 (aldehyde dehydrogenase 1 family member A1) are markers that identify dopamine neurons (dopamine neurons) located in the midbrain, which is a type of neuron necessary for transplantation to treat Parkinson's disease.
The presence of these markers at a high level indicates the success of creating pure dopamine neurons and suitable for clinical or research applications. |
Research and development of therapeutic cells for Parkinson's disease often use biomarkers (biomarkers) to confirm the uniqueness and purity of the cells produced.
The STEM-PD production protocol is specifically designed to obtain cells with high expression of GIRK2 and ALDH1A1, which is a key principle to ensure the quality and safety of cell therapy products. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
Growth factors like FGF8b (fibroblast growth factor 8b) and SHH (Sonic hedgehog) are crucial signaling molecules involved in developmental processes, including the patterning and differentiation of neural cells. In the manufacturing process of STEM-PD (likely a process related to generating dopamine neurons from stem cells for Parkinson's disease treatment), these factors are used to guide stem cells toward specific neural fates, ensuring they develop into the desired cell types for therapeutic use. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
Theory of thinking / reference in the answer value
Scientific research or clinical trials related to rats (rats) often focuses on the recovery of the nervous system or body function, such as the recovery of movement (motor function), which is a clearly measurable and important result in preclinical experiments. Other results such as the increase in life expectancy (Increase in Lifespan) or the development of new intellectual abilities (Development Of New Cognitive Abilities) are often long-term or more complex results. And the reduction of brain size (Reduction In Brain Size) or anxiety-Like Behaviors (Anxiety-Like Behaviors) are often side effects or toxicity indicators rather than the effectiveness of drugs or treatments. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|